| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 |
| filingDate |
2005-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cab824dc888aa982604ea2e3566715f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc47f4b17dbbf76dd2a17eb0c7a065a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63efff62641cbd9582a2504c40167fcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6747a7d6a413af2bec0ead90b405838
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a9fc85f5a1ffb4f1552eaaac1186d45 |
| publicationDate |
2007-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-PA06011673-A |
| titleOfInvention |
ANTIBODIES FOR THE ERYTHROPOYETINE RECEPTOR AND ITS USES. |
| abstract |
The present invention relates to antibodies and their antigen binding portions that bind to and activate an erythropoietin receptor. The invention also relates to nucleic acid sequences encoding said antibodies and antigen binding portions. The present invention also relates to methods for activating the endogenous activity of an erythropoietin receptor in a mammal using said antibodies and antigen binding portions, treatment methods, as well as pharmaceutical compositions comprising said antibodies and antigen binding portions. |
| priorityDate |
2004-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |